Safety Aspects of Fish Oils

Experiences with an n-3 Concentrate of Re-Esterified Triglycerides (Pikasol®)

This is a preview of subscription content, log in to check access.

References

  1. Frohlich ED. Uric acid: a risk factor for coronary heart disease. Journal of the American Medical Association 270: 378–379, 1993

    PubMed  Article  CAS  Google Scholar 

  2. Kannel WB, Anderson K, Wilson PWF. White blood cell count and cardiovascular disease: insights from the Framingham study. Journal of the American Medical Association 267: 1253–1256, 1992

    PubMed  Article  CAS  Google Scholar 

  3. Kristensen SD, Schmidt EB, Dyerberg J. Dietary supplementation with n-3 polyunsaturated fatty acids and human platelet function: a review with particular emphasis on implications for cardiovascular disease. Journal of Internal Medicine 225 (Suppl. 1): 141–150, 1989

    Google Scholar 

  4. Leaf A, Weber PC. Cardiovascular effects of n-3 fatty acids. New England Journal of Medicine 318: 549–557, 1988

    PubMed  Article  CAS  Google Scholar 

  5. Nordøy A. Is there a rational use for n-3 fatty acids (fish oils) in clinical medicine? Drugs 42: 331–342, 1991

    PubMed  Article  Google Scholar 

  6. Schmidt EB, Dyerberg J. Omega-3 fatty acids: current status in cardiovascular medicine. Drugs 7: 405–424, 1994

    Article  Google Scholar 

  7. Schmidt EB, Ernst E, Vanning K, Pedersen JO, Dyerberg J. The effect of n-3 fatty acids on lipids and haemostasis in patients with type IIa and type IV hyperlipidaemia. Thrombosis and Haemostasis 62: 797–801, 1989a

    PubMed  CAS  Google Scholar 

  8. Schmidt EB, Lervang H-H, Varming K, Madsen P, Dyerberg J. Long term supplementation with n-3 fatty acids. I: effects on blood lipids, hemostasis and blood pressure. Scandinavian Journal of Clinical and Laboratory Investigation 52: 221–228, 1992

    PubMed  Article  CAS  Google Scholar 

  9. Schmidt EB, Nielsen LK, Pedersen JO, Kornerup HJ, Dyerberg J. The effect of n-3 polyunsaturated fatty acids on lipids, platelet function, coagulation, fibrinolysis and monocyte chemotaxis in patients with hypertension. Clinica Chimica Acta 189: 25–32, 1990a

    Article  CAS  Google Scholar 

  10. Schmidt EB, Sørensen PJ, Pedersen JO, Jersild C, Ditzel J, et al. The effect of n-3 polyunsaturated fatty acids on lipids, haemostasis, neutrophil and monocyte chemotaxis in insulin-dependent diabetes mellitus. Journal of Internal Medicine 225 (Suppl 1): 201–206, 1989b

    Google Scholar 

  11. Schmidt EB, Varming K, Ernst E, Madsen P, Dyerberg J. Dose-response studies on the effect of n-3 polyunsaturated fatty acids on lipids and haemostasis. Thrombosis and Haemostasis 63: 1–5, 1990b

    PubMed  CAS  Google Scholar 

  12. Siegel S, Castellan NJ. Nonparametric statistics for the behavioral sciences. McGraw-Hill, New York, 1988

    Google Scholar 

  13. Simopoulos AR. Omega-3 fatty acids in health and disease and in growth and development. American Journal of Clinical Nutrition 54: 438–463, 1991

    PubMed  CAS  Google Scholar 

  14. Witzkum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. Journal of Clinical Investigation 88: 1785–1792, 1991

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Jørn Dyerberg.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Schmidt, E.B., Møller, J.M., Svaneborg, N. et al. Safety Aspects of Fish Oils. Drug Invest 7, 215–220 (1994). https://doi.org/10.1007/BF03257413

Download citation

Keywords

  • Uric Acid
  • Drug Invest
  • Tocopherol Level
  • Monocyte Chemotaxis
  • Term Supplementation